Blackbaud (BLKB) Q4 2025 Earnings Transcript

Blackbaud reported 2025 organic revenue growth of 5.5% to $1.128 billion, adjusted EBITDA of $405 million (+8%) with a 35.9% margin, and adjusted free cash flow of $208 million, while repurchasing about 8% of shares outstanding. Management said it achieved Rule of 40 two years early and guided 2026 organic revenue growth of 4%-4.5%, adjusted EBITDA of $430 million-$438 million, and EPS of $5.15-$5.25, alongside $280 million-$290 million in free cash flow. The company also emphasized AI product launches and internal AI-driven productivity, plus a plan to return at least 50% of cumulative 2026-2030 free cash flow via buybacks.

Analysis

BLKB is transitioning from a “stabilization” story to a self-funding compounding story: the important signal is not the headline growth rate, but the widening gap between organic revenue and cash generation. The company is effectively using AI and India-based labor arbitrage to turn a mid-single-digit growth profile into double-digit EPS growth, which matters because the market typically pays a much higher multiple for durable margin expansion plus buybacks than for top-line acceleration alone. The step-up in free cash flow also creates an unusually powerful mechanical bid for the stock over the next 12-24 months, since repurchases are now a formal capital allocation pillar rather than opportunistic usage.

The underappreciated second-order effect is that longer contracts and stronger retention reduce near-term volatility while also lowering the perceived risk of monetizing new AI modules. That gives management room to layer on a premium “workflow automation” price point without needing a broad base of new customers to prove the model first. If the first agentic product gains traction, the real upside is not the standalone subscription fee; it is the attachment rate into payments and transactional revenue, which could create a higher-quality recurring mix and justify a multiple re-rating.

The main risk is that the market may initially over-earn the AI upside and underweight the quarterly sequencing drag: tougher compares in the first half and heavier expense in the back half could create a few noisy prints even if the full-year thesis remains intact. The bigger contrarian point is that the stock may still be underowned relative to the quality of the cash-return story because investors may screen BLKB as a slow-growth vertical SaaS name rather than a buyback compounder with explicit EPS accretion. That said, the valuation will likely hinge on whether management can convert “AI optionality” into measurable net revenue retention and incremental payments volume by late 2026.

Key Decisions for Investors

• Go long BLKB on post-earnings weakness over the next 2-6 weeks; the setup favors buying dips because 2026 EPS growth is increasingly share-count driven, which should support multiple stability even if revenue comes in at the low end of guide.
• Pair trade: long BLKB / short a basket of slower-growth vertical SaaS names with weaker free-cash-flow conversion; BLKB has the cleaner buyback catalyst and clearer path to margin expansion over the next 12 months.
• Buy BLKB Jan-2027 call spreads if implied vol is reasonable; thesis is that the market will re-rate the stock once it sees whether the first AI product starts contributing to payments and renewal rates by H2 2026.
• Use a staggered entry around the first-half revenue compare risk: size 1/2 now, add on any Q1/Q2 selloff if management reiterates full-year FCF and repurchase cadence.
• Risk control: if renewals or transactional growth slip below historical norms for two consecutive quarters, reduce exposure quickly, because the bull case depends on the buyback engine remaining funded by real cash, not adjusted metrics.